Specifically, OXPHOS blockade markedly reduced activation of TGFβ and MAPK pathways and reversed EMT phenotypes in breast cancer cells undergoing osteogenic differentiation (Hu et al., 2020). Here, TGFB1 is linked to breast carcinoma.